BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Aug 22, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Opaxio paclitaxel poliglumex: Phase II started

Cell Therapeutics began a Phase II trial to evaluate once-weekly Opaxio plus radiotherapy vs. once-daily oral temozolomide plus radiotherapy for 6 weeks in about 60 patients. After 6 weeks, both arms...

Read the full 131 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >